Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.
Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, Dattagupta S, et al. PLoS One. 2011 May 5; 6(5):e19213. Epub 2011 May 5.